AdaptHealth Corp. (NASDAQ: AHCO)

AdaptHealth Corp., with the ticker symbol AHCO, operates in the healthcare industry, specifically as a national leader in providing patient-centered, healthcare-at-home solutions. These solutions encompass home medical equipment (HME), medical supplies, and related services. The company's primary focus is on providing sleep therapy equipment, medical devices, and supplies to patients suffering from obstructive sleep apnea (OSA), diabetes management supplies, home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies to chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

AdaptHealth's main business activities revolve around the provision of HME products and related services. The company generates revenue through the sale of HME products such as CPAP equipment, wheelchairs, hospital beds, oxygen concentrators, insulin pumps, and other similar products. It also offers related services, making it a comprehensive provider in the HME market. AdaptHealth operates in several segments, each with its unique characteristics. These segments include Sleep Therapy, Diabetes, Home Medical Equipment, Oxygen and Related Chronic Therapy Services, and Other HME Devices and Supplies.

In the highly competitive HME market, AdaptHealth competes with other large national providers, regional providers, and product-specific providers. The company believes its competitive advantages lie in its quality of patient care, service quality, differentiated technology platform, reputation with referral sources, comprehensive offering across the HME space, broad network of payor contracts, and overall ease of doing business. AdaptHealth's customer base includes beneficiaries of Medicare, Medicaid, and commercial insurance payors.

AdaptHealth has a strong presence in the market, with approximately 680 locations in 47 states. It services approximately 4.1 million patients annually, demonstrating its significant reach and impact in the healthcare industry. The company employs around 10,700 people and is committed to inclusion and diversity, with a Diversity and Inclusion Council that leads learning activities around leading inclusively, inclusion in the workforce, and unconscious bias.

AdaptHealth's product and service portfolio includes a range of offerings. In the Sleep Therapy segment, the company provides sleep therapy equipment, supplies, and related services to patients suffering from OSA. The Diabetes segment offers medical devices and supplies to patients with diabetes, including continuous glucose monitors (CGMs) and insulin pumps. The Home Medical Equipment segment provides HME products to patients discharged from acute care and other facilities. The Oxygen and Related Chronic Therapy Services segment offers oxygen and related chronic therapy services in the home. Lastly, the Other HME Devices and Supplies segment provides HME devices and supplies to chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.